The Financial Report — Volume 2, No. 11
Last week, The Wall Street Journal published an interesting editorial entitled ‘Regulator for the World’. The editorial strongly blasted Commodity Futures Trading Commission (CFTC) chairman Gary Gensler for attempting to regulate even foreign transactions that involve a US person. The journal suggests that the CFTC’s rules are directly responsible for encouraging foreign firms to do whatever they can to avoid coming within US jurisdiction, including cutting off business with American counterparties.
Perhaps most troubling, according to the journal, is that the CFTC has not undertaken any meaningful cost-benefit analysis to determine whether the CFTC’s attempt to oversee the global trading of derivatives ultimately will cause foreign market participants to avoid the US, which in turn might substantially damage the US as a global financial center.
The journal, in contrast, back-handedly compliments the Securities and Exchange Commission (SEC) for its proposed rules, which, at least, ‘provide hope that Dodd-Frank can be imposed without disrupting global finance’. In addition, the journal continues, ‘the SEC is making an attempt at identifying costs and benefits’…
If you are registered and logged in to the site, click on the link below to read the rest of the DLA Piper briefing. If not, please register or sign in with your details below.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from DLA Piper
News from The Lawyer
Briefings from DLA Piper
Health Alert — Julia Clare v Australian Community Pharmacy Authority; Dr Reid v Medical Council of NSW; and more
DLA Piper has released the 22 December 2014 issue of its Health Alert, which focuses on judgments, legislation and reports in the health sector.
The European Court of Justice (CJEU) has handed down a landmark judgment concerning the patentability of stem cells in Europe.
Analysis from The Lawyer
Regulators are ramping up the pressure in the aftermath of recession, leaving firms to compete for compliance and restructuring work
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.